Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 10Recruiting 5Active not recruiting 4Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 64Colorectal Neoplasms 58Rectal Neoplasms 46Stomach Neoplasms 44Neoplasm Metastasis 16Pancreatic Neoplasms 15Colonic Neoplasms 13Triple Negative Breast Neoplasms 11Neoplasms 11Esophageal Neoplasms 9Nasopharyngeal Carcinoma 8Locally Advanced Rectal Cancer 7Esophageal Squamous Cell Carcinoma 7Cholangiocarcinoma 6Biliary Tract Neoplasms 6Carcinoma, Hepatocellular 5HER2 Positive Metastatic Breast Cancer 4Colorectal Cancer Metastatic 4Adenocarcinoma 4Solid Tumor 3Recurrence 3Gallbladder Neoplasms 3Anus Neoplasms 3Advanced Breast Cancer 3Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Neuroendocrine Tumors 2Locally Advanced Colon Cancer 2Hyperthermia 2Head and Neck Neoplasms 2

Interventions

Fluorouracil 5Radiotherapy 3Paclitaxel 3Leucovorin 3Endoscopy 3Cisplatin 3Oxaliplatin 2Neoadjuvant Therapy 2Endoscopy, Digestive System 2Endoscopic Mucosal Resection 2Carboplatin 2tremelimumab 1rucaparib 1rubitecan 1durvalumab 1Taxes 1Surveys and Questionnaires 1Ramucirumab 1Radiation 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Microarray Analysis 1Magnetic Resonance Imaging 1Irinotecan 1High-Throughput Screening Assays 1Genetic Linkage 1Epirubicin 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Drug Therapy 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma Of Esophagus × Capecitabine × Clear all
NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Wales Cancer Trials Unit

Phase 2/3 Unknown
259 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡